| Everest Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524790 |
NSE Symbol : - |
P/E(TTM) : 64.19 |
|
ISIN Demat : INE334C01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 6.81 |
|
Book Value(₹) : 74.67 |
Market Cap(₹Cr) : 424.50 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 51.00 | 53.81 | 40.93 | 42.05 | 44.05 | 32.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 51.00 | 53.81 | 40.93 | 42.05 | 44.05 | 32.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.29 | 0.55 | 0.22 | 0.00 | 0.14 | 0.33 |
| Total Income | 51.29 | 54.36 | 41.15 | 42.06 | 44.19 | 32.77 |
| Total Expenditure | 45.87 | 49.38 | 37.50 | 38.03 | 40.62 | 36.10 |
| PBIDT | 5.42 | 4.99 | 3.65 | 4.02 | 3.57 | -3.33 |
| Interest | 1.23 | 1.31 | 1.15 | 1.40 | 1.35 | 1.29 |
| PBDT | 4.19 | 3.68 | 2.51 | 2.62 | 2.22 | -4.62 |
| Depreciation | 1.52 | 1.52 | 1.56 | 1.47 | 1.47 | 1.47 |
| Tax | 0.91 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.61 | 0.40 | -1.96 | 0.01 | 0.01 | 0.00 |
| Reported Profit After Tax | 1.16 | 1.41 | 2.91 | 1.14 | 0.74 | -6.09 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.16 | 1.41 | 2.91 | 1.14 | 0.74 | -6.09 |
| EPS (Unit Curr.) | 1.19 | 1.45 | 3.00 | 1.42 | 0.93 | -7.61 |
| EPS (Adj) (Unit Curr.) | 1.19 | 1.45 | 3.00 | 1.42 | 0.93 | -7.61 |
| Calculated EPS (Unit Curr.) | 1.19 | 1.45 | 3.00 | 1.42 | 0.93 | -7.61 |
| Calculated EPS (Adj) (Unit Curr.) | 1.19 | 1.45 | 3.00 | 1.42 | 0.93 | -7.61 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.76 | 5.79 | 12.00 | 5.70 | 3.70 | -30.45 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.76 | 5.79 | 12.00 | 5.70 | 3.70 | -30.45 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.71 | 9.71 | 9.71 | 8.00 | 8.00 | 8.00 |
| Reserve & Surplus | 62.80 | 61.64 | 60.24 | 33.64 | 32.49 | 31.75 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.63 | 9.27 | 8.92 | 9.56 | 8.10 | -10.26 |
| PBDTM(%) | 8.22 | 6.84 | 6.13 | 6.23 | 5.04 | -14.24 |
| PATM(%) | 2.27 | 2.62 | 7.11 | 2.71 | 1.68 | -18.77 |